Here’s whether SRX Health Solutions, Inc. (SRXH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: RSI 48 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.80% over 10 days); weak 1-year return of -81.4%. Currently 84.5% off its 52-week high. Score: -4/7.
SRXH is trading below its 200-day MA ($0.23) — a key warning sign the longer-term trend is under pressure. An RSI of 47.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -81.4% compares to +24.4% for SPY (trailed the market by 105.7%). The current 84.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $1,864 today
vs. S&P 500 (SPY) — same period trailed market by 105.7%